Everolimus With Reduced Exposure to a Calcineurin Inhibitor in Pediatric Liver Transplant Recipients: Baseline Data From the H2305 Study.

被引：0
|
作者：
Ganschow, R. [1 ]
Fischer, L. [1 ]
Ericzon, B. [1 ]
Dhawan, A. [1 ]
D'Alessandro, A. [1 ]
Goss, J. [1 ]
Sips, C. [1 ]
Balfour, A. [1 ]
Junge, G. [1 ]
机构：
[1] H2305 Study Grp, Hamburg, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B1060
引用
收藏
页码：719 / 719
页数：1
相关论文
共 50 条
  • [21] EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING-DONOR LIVER TRANSPLANT RECIPIENTS: BASELINE DATA FROM THE H2307 STUDY
    Settmacher, U.
    Braun, F.
    Sips, C.
    Dong, G.
    Kroeger, I.
    Sanchez, J. Aguilar
    TRANSPLANT INTERNATIONAL, 2015, 28 : 32 - 32
  • [22] EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING-DONOR LIVER TRANSPLANT RECIPIENTS: BASELINE DATA FROM THE H2307 STUDY
    Lopez, Patricia
    Levy, Gary
    Jeng, Long-Bin
    Suh, Kyung Suk
    Joo, Dong Jin
    Lee, Sung Gyu
    Lee, Wei-Chen
    Chen, Chao-Long
    Soin, Arvinder Singh
    Joh, Jae Won
    Yoshizumi, Tomoharu
    Grant, David
    Martzloff, El-Djouher
    Sips, Carole
    Wang, Zailong
    TRANSPLANT INTERNATIONAL, 2015, 28 : 459 - 459
  • [23] Everolimus with Reduced-Dose Calcineurin Inhibitor versus Mycophenolate with Standard-Dose Calcineurin Inhibitor in De Novo Kidney Transplant Recipients: Renal Function Results from the TRANSFORM Study.
    Oppenheimer, F.
    Legendre, C.
    Cruzado, J.
    Russ, G.
    Viklicky, O.
    Oberbauer, R.
    Garcia, V.
    Witzke, O.
    Kuypers, D.
    Danguilan, R.
    Bernhardt, P.
    Sommerer, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 258 - 258
  • [24] Renal Function Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus with Reduced-Exposure Calcineurin Inhibitor versus Mycophenolate with Standard-Exposure Calcineurin Inhibitor: Results from the TRANSFORM Study
    Oppenheimer, Federico
    Russ, Graeme
    Viklicky, Ondrej
    Oberbauer, Rainer
    Garcia, Valter
    Witzke, Oliver
    Kuypers, Dirk
    Danguilan, Romina
    Das Gupta, Ayan
    Bernhardt, Peter
    Sommerer, Claudia
    TRANSPLANTATION, 2018, 102 : S363 - S363
  • [25] RATIONALE, DESIGN AND BASELINE CHARACTERISTICS OF PEDIATRIC RENAL TRANSPLANT RECIPIENTS IN CRADLE STUDY: A RANDOMISED STUDY TO EVALUATE THE EFFECT OF EARLY EVEROLIMUS INITIATION TO REDUCE CALCINEURIN INHIBITOR EXPOSURE AND TO WITHDRAW STEROID
    Pape, Lars
    TOenshoff, Burkhard
    Ettenger, Robert
    Dello Strologo, Luca
    Martzloff, El-djouher
    Ng, Jennifer
    Lopez, Patricia
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1712 - 1712
  • [26] Everolimus With Reduced Calcineurin Inhibitor in Thoracic Transplant Recipients With Renal Dysfunction: A Multicenter, Randomized Trial
    Gullestad, Lars
    Iversen, Martin
    Mortensen, Svend-Aage
    Eiskjaer, Hans
    Riise, Gerdt C.
    Mared, Lena
    Bjortuft, Oystein
    Ekmehag, Bjorn
    Jansson, Kjell
    Simonsen, Svein
    Gude, Einar
    Rundqvist, Bengt
    Fagertun, Hans E.
    Solbu, Dag
    Bergh, Claes-Hakan
    TRANSPLANTATION, 2010, 89 (07) : 864 - 872
  • [27] Antirejection Efficacy in De Novo Renal Transplant Recipients Receiving Everolimus with a Reduced-Exposure Calcineurin Inhibitor-Based Regimen: 24-Month Results from the TRANSFORM Study.
    Silva, H. Tedesco
    Citterio, F.
    Henry, M.
    Srinivas, T. R.
    Watarai, Y.
    Steinberg, S.
    Basic-Jukic, N.
    Garcia, V. D.
    Mor, E.
    Peddi, V. R.
    Narvekar, P.
    Gutierrez, M. P. Hernandez
    Bernhardt, P.
    Pascual, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 358 - 359
  • [28] EFFICACY AND SAFETY OF EVEROLIMUS (EVR) WITH REDUCED EXPOSURE TACROLIMUS OR CYCLOSPORINE IN PEDIATRIC LIVER TRANSPLANTATION RECIPIENTS (PLTXR): 24-MONTH RESULTS FROM H2305-STUDY (NCT01598987)
    Ganschow, R.
    Ericzon, B. G.
    Dhawan, A.
    Sharif, K.
    Martzloff, E. D.
    Rauer, B.
    Ng, J.
    Lopez, P. M.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 37 - 37
  • [29] CONVERSION OF STABLE ABO-INCOMPATIBLE KIDNEY TRANSPLANT RECIPIENTS FROM MYCOPHENOLATE MOFETIL WITH STANDARD EXPOSURE CALCINEURIN INHIBITOR TO EVEROLIMUS WITH VERY LOW EXPOSURE CALCINEURIN INHIBITOR
    Uchida, Junji
    Machida, Yuichi
    Kabei, Kazuya
    Iwai, Tomoaki
    Kuwabara, Nobuyuki
    Naganuma, Toshihide
    Kumada, Norihiko
    Nakatani, Tatsuya
    TRANSPLANT INTERNATIONAL, 2013, 26 : 248 - 248
  • [30] Effect of Everolimus with Reduced Calcineurin Inhibitor on Efficacy and Safety in De Novo Kidney Transplant Recipients: 12-Month Results from the US Cohort of TRANSFORM Study.
    Mulgaonkar, S.
    Qazi, Y.
    Kim, D.
    Peddi, V.
    McCague, K.
    Patel, D.
    Wiseman, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 259 - 259
12345